With solo travel bigger than ever, Globus and Cosmos have hopped on the trend with Globus completely waiving the single supplement fee off select Globus Escapes Europe tours, while Cosmos is offering ...

Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...

Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

Wall Street analysts expect Globus Medical (GMED) to post quarterly earnings of $0.76 per share in its upcoming report, which indicates a year-over-year increase of 26.7%. Revenues are expected to be ...

StockNews.com upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...

From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

Globus Maritime, the public shipping arm of Greece’s Feidakis family, has sold its oldest bulker as part of long-term fleet renewal plans. The Athens-based company announced late on Tuesday the sale ...

About Globus Maritime Limited, Globus is an integrated dry bulk shipping company that provides marine transportation services worldwide. The Company’s operating fleet consists of ten dry bulk vessels ...

Globus Medical GMED has outperformed the market over the past 10 years by 2.41% on an annualized basis producing an average annual return of 13.55%. Currently, Globus Medical has a market ...